Ann: Trading Halt, page-84

True. we do need to look past the spin. And one of the main parties who will be able to do that - Big Pharma. To continue, Actinogen will need more money for Phase 3 (if the results warrant it), and this will only really come from shareholders or Big Pharma partnership / buyout. They will know what the results mean better than the market i imagine.

Also, for those who think the proposed depression / mental health trials are a sign that we've failed on AD, I think you're either trolling or haven't done your research. We aren't about a cure for AD, we are about improving cognitive decline involving a hypothesis around cortisol, where the first target for this was AD. Other diseases show a similar correlation of increased cortisol and cognitive decline, and therefore will be targeted next, IF these results are good. We aren't playing for an AD cure, but an alleviation of symptoms of cognitive decline.

All the best everyone,